Physician communication about adolescent vaccination: How is human papillomavirus vaccine different?
Physician communication about adolescent vaccination: How is human papillomavirus vaccine different?
复制标题
DOI：
10.1016/j.ypmed.2015.05.024
复制
发表时间：
2015-08-01
影响因子：
5.1
通讯作者：
Brewer, Noel T.
中科院分区：
文献类型：
--
作者：
Gilkey, Melissa B.;Moss, Jennifer L.;Brewer, Noel T.
背景。人乳头瘤病毒（HPV）疫苗接种率低与我们在提供其他青少年疫苗方面取得的成功形成鲜明对比。为了确定改善医生对HPV疫苗接种建议的机会，我们试图了解围绕青少年疫苗接种的沟通背景如何因疫苗类型而异。2014年，776名美国医生（53%的儿科医生，47%的家庭医学医生）完成了我们的在线调查。我们评估了医生在向11岁和12岁的患者推荐青少年疫苗方面的看法和沟通做法。约有四分之三的医生（73%）推荐HPV疫苗对11-12岁的患者非常重要。更多的医生推荐破伤风、白喉和无细胞百日咳（Tdap）（95%）和脑膜炎球菌疫苗（87%）
Background. Low human papillomavirus (HPV) vaccination coverage stands in stark contrast to our success in delivering other adolescent vaccines. To identify opportunities for improving physicians' recommendations for HPV vaccination, we sought to understand how the communication context surrounding adolescent vaccination varies by vaccine type.Methods. A national sample of 776 U.S. physicians (53% pediatricians, 47% family medicine physicians) completed our online survey in 2014. We assessed physicians' perceptions and communication practices related to recommending adolescent vaccines for 11- and 12-year-old patients.Results. About three-quarters of physicians (73%) reported recommending HPV vaccine as highly important for patients, ages 11-12. More physicians recommended tetanus, diphtheria, and acellular pertussis (Tdap) (95%) and meningococcal vaccines (87%, both p